(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

Fox News senior medical analyst Dr. Marc Siegel reveals what he learned from his interview with National Institutes of Health ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

The list seems to have been used as research for the 2024 book, "Toxic Shot: Facing the Dangers of the COVID 'Vaccines.'" The ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

Michigan State University’s director of the Precision Health Program, Anna Moore, says canceling federal mRNA vaccine ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.